The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chang David D since 2015.
This trader's CIK number is 1611024.
At the time of last reporting, Chang David D was the President and CEO of Allogene Therapeutics, Inc.. (stock ticker symbol ALLO).
Also see all insider trading activities at Allogene Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ALLO | 0 | $0 | 92,671 | $168,754 | 0 | $0 |
| 2022 | ALLO | 0 | $0 | 23,648 | $180,883 | 0 | $0 |
| 2021 | ALLO | 0 | $0 | 20,513 | $791,268 | 27,410 | $499,410 |
| 2020 | ALLO | 0 | $0 | 20,335 | $399,643 | 0 | $0 |
| 2018 | ALLO | 40,000 | $720,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | KITE | 0 | $0 | 87,927 | $7,840,796 | 80,000 | $551,200 |
| 2016 | KITE | 0 | $0 | 1,788 | $90,937 | 0 | $0 |
| 2015 | KITE | 4,000 | $68,000 | 77,000 | $5,328,191 | 77,000 | $530,529 |
1. Allogene Therapeutics, Inc. (ALLO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-14 | ALLO | Sale | 46,668 | 1.96 | 91,469 |
| 2025-02-03 | ALLO | Sale | 46,003 | 1.68 | 77,285 |
| 2022-03-15 | ALLO | Sale | 23,648 | 7.65 | 180,883 |
| 2021-05-24 | ALLO | Option Ex | 27,410 | 18.22 | 499,410 |
| 2021-03-15 | ALLO | Sale | 20,513 | 38.57 | 791,268 |
| 2020-03-16 | ALLO | Sale | 20,335 | 19.65 | 399,643 |
| 2018-10-15 | ALLO | Buy | 40,000 | 18.00 | 720,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-25 | KITE | Sale | 7,927 | 179.66 | 1,424,196 |
| 2017-05-01 | KITE | Option Ex | 20,000 | 6.89 | 137,800 |
| 2017-05-01 | KITE | Sale | 20,000 | 82.60 | 1,652,000 |
| 2017-03-01 | KITE | Option Ex | 60,000 | 6.89 | 413,400 |
| 2017-03-01 | KITE | Sale | 60,000 | 79.41 | 4,764,600 |
| 2016-12-20 | KITE | Sale | 1,788 | 50.86 | 90,937 |
| 2015-11-10 | KITE | Option Ex | 30,800 | 6.89 | 212,212 |
| 2015-11-10 | KITE | Sale | 30,800 | 80.02 | 2,464,616 |
| 2015-11-02 | KITE | Option Ex | 7,700 | 6.89 | 53,053 |
| 2015-11-02 | KITE | Sale | 7,700 | 70.11 | 539,870 |
| 2015-10-01 | KITE | Option Ex | 7,700 | 6.89 | 53,053 |
| 2015-10-01 | KITE | Sale | 7,700 | 55.11 | 424,347 |
| 2015-09-03 | KITE | Option Ex | 316 | 6.89 | 2,177 |
| 2015-09-08 | KITE | Sale | 7,384 | 55.00 | 406,120 |
| 2015-09-08 | KITE | Option Ex | 7,384 | 6.89 | 50,875 |
| 2015-09-03 | KITE | Sale | 316 | 55.00 | 17,380 |
| 2015-08-03 | KITE | Option Ex | 7,700 | 6.89 | 53,053 |
| 2015-08-03 | KITE | Sale | 7,700 | 72.56 | 558,712 |
| 2015-07-01 | KITE | Option Ex | 7,700 | 6.89 | 53,053 |
| 2015-07-01 | KITE | Sale | 7,700 | 62.14 | 478,501 |
| 2014-06-25 | KITE | Buy | 4,000 | 17.00 | 68,000 |
| 2015-06-15 | KITE | Option Ex | 7,700 | 6.89 | 53,053 |
| 2015-06-15 | KITE | Sale | 7,700 | 56.97 | 438,645 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chang David D (President and CEO of Allogene Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.